• Mar 18, 2025

3 Reasons to Sell PACB and 1 Stock to Buy Instead

Shareholders of PacBio would probably like to forget the past six months even happened. The stock dropped 35.2% and now trades at $1.25. This was partly due to its softer quarterly results and might have investors contemplating their next move.

  • Mar 18, 2025

3 Reasons to Sell VSTS and 1 Stock to Buy Instead

Over the last six months, Vestis’s shares have sunk to $12.66, producing a disappointing 16.7% loss while the S&P 500 was flat. This may have investors wondering how to approach the situation.